- Home » News and EventsPage 17
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Aug 4, 2020
Catalent today announced that it will expand its Argentinian site in Loma Hermosa, Buenos Aires. The expansion will be segregated and designed to handle cytotoxic and highly active products for prescription softgel manufacturing.
Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline
Jul 29, 2020
Catalent will support the development, manufacturing, and clinical supply of Editas Medicine’s portfolio of in vivo CRISPR medicines and engineered cell medicines.
Catalent Biologics’ Executive to Discuss Manufacturing Scale-up During a Pandemic
Jul 22, 2020
Catalent today announced that Mike Riley, Region President, Biologics, North America, will present at the upcoming Disease Prevention & Control Summit, taking place virtually on July 28 – 29, 2020.
Catalent Biologics to Invest $30 Million to Create European Clinical Manufacturing Center of Excellence in Limoges, France
Jul 21, 2020
Catalent today announced that it plans to invest $30 million (€27 million) at its facility in Limoges, France, to create a European center of excellence for clinical biologics formulation development and drug product fill-finish services.
Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab
Jul 16, 2020
Catalent and Humanigen today announced the expansion of their relationship, under which Catalent will provide development, manufacturing and commercialization services for lenzilumab.
Catalent Completes Purchase of Pharmaceutical Clinical Packaging Facility in Shiga, Japan
Jul 1, 2020
Catalent today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
Catalent Expands Beauty and Plant-Based Consumer Health Softgel Capabilities at its Facilities in Canada and Brazil
Jun 30, 2020
Catalent today announced the completion of a $3.2 million expansion program at its consumer health manufacturing facilities in Strathroy, Canada and Sorocaba, Brazil.
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Jun 25, 2020
Moderna and Catalent today announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate at Catalent’s biologics facility in Bloomington, Indiana.
Catalent to Discuss Data-Driven Approaches for Small Molecule Drug Development at the Controlled Release Society Annual Meeting
Jun 24, 2020
Catalent today announced that a number of its experts will present at the upcoming Controlled Release Society (CRS) Annual Meeting, which will take place virtually on June 29 – July 2, 2020.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.